Clinical trials for neuropathy are research studies where people with nerve damage work with medical teams to test new treatments, medications, or approaches. These aren't the same as getting standard medical care at your doctor's office. Instead, you'd be participating in a structured research project with specific rules, timelines, and monitoring.
Learn About Paying Your FGUA Bill Online →
Neuropathy—damage to the peripheral nerves that carry signals between your brain, spinal cord, and the rest of your body—affects millions of people. Common types include diabetic neuropathy (affecting about 30% of people with diabetes), chemotherapy-related peripheral neuropathy (CIPN), and idiopathic neuropathy when doctors can't pinpoint the cause. Because neuropathy is difficult to treat with existing medications, researchers continuously test new options.
A clinical trial might test a new drug that could reduce nerve pain, a physical therapy technique, a device that delivers electrical stimulation, or even a way to help your body repair damaged nerves. Some trials examine whether a treatment works at all (Phase 1), others compare it to current treatments (Phase 2 and 3), and some track long-term safety after approval (Phase 4).
The key difference from regular treatment: in a trial, researchers are collecting data about what happens to you and many others. Your participation generates the information that helps doctors understand whether something truly works. This means extra appointments, more detailed records, and structured follow-ups—but also potentially access to treatments not yet available outside research settings.
Takeaway: Clinical trials aren't experimental guesswork—they're systematic ways researchers test whether new neuropathy treatments actually work. Understanding this structure helps you evaluate whether participation makes sense for your situation.
The most practical starting point is ClinicalTrials.gov, a free database run by the National Institutes of Health that lists nearly every clinical trial conducted in the United States. You can search by condition (neuropathy), location (your state or city), and trial status. When you search "neuropathy" on the site, you'll find hundreds of studies—some recruiting actively, others full or closed.
Free Guide to Pay by Plate Illinois Billing →
To narrow results to your area, you can filter by city, state, or zip code. The site shows you the trial name, what condition it's studying, what phase it's in, where it's happening (hospital, university, private research center), and contact information. Each trial listing includes a detailed description of what participants do, what they're testing, and what the researchers are measuring.
Beyond ClinicalTrials.gov, university medical centers and teaching hospitals often run neuropathy studies. These institutions typically have neurology or pain management departments actively recruiting for research. You can call the neurology department at major hospitals near you and ask whether they're running any peripheral neuropathy trials. Many keep lists of ongoing studies on their websites too.
Specialty research organizations matter as well. Groups like the American Diabetes Association, the National Neuropathy Association, and condition-specific foundations sometimes maintain registries of studies or can direct you to trials related to your type of neuropathy. Some pharmaceutical companies sponsor trials through their websites or patient recruitment services.
Note that "near you" varies depending on how far you can travel. Some people can visit a research site weekly; others can't. Check whether trials require frequent visits to one location or whether some visits can happen by video or phone—this information is usually listed.
Takeaway: Start with ClinicalTrials.gov and filter by your location, then expand to local hospitals and specialty organizations. The trial that's "near you" depends on how far you're willing to travel for appointments.
Before considering any neuropathy trial, you need to understand the real time and effort commitment. Some studies require one visit per month for six months. Others need weekly appointments for a year. A few involve overnight hospital stays or intensive screening visits lasting four hours. The trial information should clearly state the schedule—read this carefully, because fitting study visits into your life matters.
Free Guide to Mold Removal Methods for Walls →
During visits, expect measurements of your nerve function. Researchers use tools like quantitative sensory testing (QST), where you report when you feel different temperatures or vibrations on your skin. Some trials include electromyography (EMG), which measures electrical activity in your muscles using small needles—uncomfortable but not dangerous. Many involve questionnaires about your pain, function, and quality of life. Blood draws are common. Some trials include skin biopsies, where doctors take a tiny sample of skin to count nerve fibers.
You'll also provide detailed medical history. Researchers ask about all your medications, other health conditions, surgeries, and previous treatments. They ask what makes your neuropathy better or worse, how it affects your daily life, and whether you have other nerve problems. This information helps researchers make sure the study results apply accurately to people like you.
Many trials include a "run-in period"—a few weeks where you do the testing and monitoring but don't get the experimental treatment yet. This establishes a baseline and helps researchers see who truly wants to continue. Some trials use randomization, meaning you don't choose your treatment—a computer randomly assigns you to receive either the new treatment or a placebo (fake treatment) or current standard care. This frustrates some people, but randomization is how researchers know results aren't just because people expect to improve.
You'll sign detailed consent forms explaining risks, benefits, and what you're agreeing to. Reading these carefully matters. You're never forced to stay in a trial—you can withdraw anytime, though researchers ask that you complete final safety checks.
Takeaway: Know the exact schedule before committing. Understand the testing procedures, the randomization process if there is one, and your right to leave at any time.
Neuropathy trials have specific criteria for who can participate, and these vary widely between studies. Most require you to have a confirmed diagnosis of peripheral neuropathy—not just suspicion or occasional symptoms. The type matters: a diabetic neuropathy trial won't take people with CIPN, and vice versa. Some trials only recruit people with mild or moderate symptoms, explicitly excluding severe cases. Others target only severe neuropathy where existing treatments haven't helped.
How to Delete Your Fitbit Account Guide →
Age restrictions are common. Many trials focus on adults 18 and older. Some specify a minimum age like 21 or even 50. A few study neuropathy in children, but these are less common. Some trials have upper age limits (like 75), though this is increasingly uncommon as researchers recognize that older people have neuropathy too.
Other medical conditions can disqualify you. If you have kidney disease, heart problems, or liver disease, many trials won't accept you because these conditions affect how your body processes medications. Pregnancy usually excludes you from most neuropathy trials since effects on a developing baby are unknown. Some trials exclude people with diabetes that's poorly controlled, since stable blood sugar is important for study results. Others exclude people taking certain medications that would interfere with the study drug.
Previous treatments matter. If you've recently tried a similar medication, you might be excluded from a trial testing that same drug. Some trials explicitly want people who haven't had many treatments; others want people whose existing treatments haven't worked. The logic: researchers want to study people in situations where their new treatment might actually help.
Mental health and substance use history can affect participation. Trials requiring careful compliance with visit schedules might exclude people with serious untreated depression or active substance use disorders. This isn't judgment—it's recognition that these conditions make consistent participation harder.
The important point: each trial has its own rules. Not being accepted for one trial doesn't mean you can't participate in others. Different studies want different types of participants.
Takeaway: Every trial has specific criteria—read them carefully to understand what would make you ineligible. If one trial excludes you, others may not.
Once you're enrolled, the trial moves into its main phase. If you're receiving a drug, you'll take it according to the schedule—daily, weekly, or however the protocol dictates. You'll keep detailed diaries of your symptoms, side effects, and any changes you notice. Some studies send you text reminders to take medication or complete surveys. Others use apps where you log information daily
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.